ArticleOncology letters2018

Circulating HER-2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer.

Yanlin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.